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ABSTRACT
Background
Exposure to methylmercury from fish consumption has been linked to a potentially 
increased risk of cardiovascular disease, but evidence from prior studies is equivo-
cal. Beneficial effects of the ingestion of fish and selenium may also modify such 
effects.
Methods
Among subjects from two U.S. cohorts (a total of 51,529 men and 121,700 women) 
whose toenail clippings had been stored, we prospectively identified incident cases 
of cardiovascular disease (coronary heart disease and stroke) in 3427 participants and 
matched them to risk-set–sampled controls according to age, sex, race, and smok-
ing status. Toenail mercury and selenium concentrations were assessed with the 
use of neutron-activation analysis. Other demographic characteristics, cardiovascu-
lar risk factors, fish consumption, and lifestyle habits were assessed by means of 
validated questionnaires. Associations between mercury exposure and incident car-
diovascular disease were evaluated with the use of conditional logistic regression.
Results
Median toenail mercury concentrations were 0.23 μg per gram (interdecile range, 
0.06 to 0.94) in the case participants and 0.25 μg per gram (interdecile range, 0.07 
to 0.97) in the controls. In multivariate analyses, participants with higher mercury 
exposures did not have a higher risk of cardiovascular disease. For comparisons of 
the fifth quintile of mercury exposure with the first quintile, the relative risks were 
as follows: coronary heart disease, 0.85 (95% confidence interval [CI], 0.69 to 1.04; 
P = 0.10 for trend); stroke, 0.84 (95% CI, 0.62 to 1.14; P = 0.27 for trend); and total 
cardiovascular disease, 0.85 (95% CI, 0.72 to 1.01; P = 0.06 for trend). Findings were 
similar in analyses of participants with low selenium concentrations or low overall 
fish consumption and in several additional sensitivity analyses.
Conclusions
We found no evidence of any clinically relevant adverse effects of mercury exposure 
on coronary heart disease, stroke, or total cardiovascular disease in U.S. adults at 
the exposure levels seen in this study. (Funded by the National Institutes of Health.)
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Controversy has arisen over the risks and benefits of fish consumption in adults. Fish intake is inversely associated 
with the risk of coronary heart disease, especially 
fatal coronary heart disease, and ischemic stroke.1 
Fish are also the major source of exposure to meth-
ylmercury.2,3 Chronic, low-level methylmercury 
exposure appears to cause subtle but measurable 
neurodevelopmental delay in infants, and it is rec-
ommended that women of childbearing age, preg-
nant or nursing mothers, and infants and young 
children eat no more than two servings of fish 
per week and also limit their intake of selected 
species of fish that are especially high in methyl-
mercury content.4 In adults, however, the main 
health concern is potential cardiovascular toxicity, 
as suggested by results of experiments in animals 
and limited studies in humans.2,5
Prior clinical studies of mercury exposure and 
cardiovascular diseases have been relatively small, 
and the results have been inconsistent.6-11 Thus, 
government agencies, the Institute of Medicine, 
and risk–benefit analyses have identified the ef-
fect of methylmercury exposure on cardiovascu-
lar disease as an important area of uncertainty 
that warrants further investigation, since current 
data are not sufficient to quantitatively or quali-
tatively determine the potential effects.1,12-15 We 
prospectively investigated the relationships be-
tween mercury exposure and incident cardiovas-
cular disease in two large U.S. cohorts. Because 
the trace element selenium provides protection 
against mercury toxicity in some experimental 
models,1,2 we also evaluated selenium exposure 
as a potential effect modifier.
Methods
Population and Study Design
The designs of the Health Professionals Follow-
up Study (HPFS) and Nurses’ Health Study (NHS) 
have been described previously.16,17 The HPFS is 
a prospective cohort study that enrolled 51,529 
male U.S. health professionals 40 to 75 years of 
age in 1986. The NHS is a prospective cohort 
study that enrolled 121,700 female U.S. registered 
nurses 30 to 55 years of age in 1976. Participants 
in both cohorts are followed by means of bien-
nial questionnaires on medical history, risk fac-
tors, lifestyle, and disease incidence.
We performed a nested case–control study in-
volving participants from both cohorts. The study 
was designed by the authors and approved by the 
human subjects committees of all participating 
institutions. 
In prior analyses,18-22 we found that concen-
trations of mercury and selenium in toenails are 
excellent biomarkers of usual methylmercury and 
selenium exposure. Toenail clippings were pro-
vided by 68% of HPFS participants in 1987 and by 
52% of NHS participants during the period from 
1982 through 1984. Demographic, risk-factor, 
and lifestyle characteristics of these participants 
were similar to those of participants who did not 
provide clippings (data not shown). About two 
thirds of the HPFS participants were dentists, and 
they were excluded from this analysis owing to 
occupational exposure to inorganic mercury dur-
ing dental-amalgam procedures.18 All participants 
provided implied consent by returning completed 
questionnaires and toenail samples.
Cases and Controls
Participants with incident cardiovascular disease 
(defined as nonfatal myocardial infarction, fatal 
coronary heart disease, or stroke) were identified 
from among HPFS and NHS participants who 
had provided toenail samples. Methods for ascer-
tainment of cardiovascular events in the two co-
horts have been described previously.16,17,23 When 
cardiovascular disease outcomes were reported, 
we obtained permission from participants (or 
from relatives in cases of fatal events) to review 
their medical records. Physicians who were un-
aware of other questionnaire information used 
standardized criteria to confirm and classify the 
events. Deaths were ascertained from relatives, 
postal authorities, and the National Death Index, 
and the cause of death was classified on the basis 
of medical records, death certificates, and autopsy 
findings. Permission to review medical records 
was granted for 95% of the requests.
A diagnosis of myocardial infarction was con-
firmed on the basis of standardized criteria, which 
included typical symptoms plus either diagnostic 
electrocardiographic changes or elevated cardiac 
enzyme levels.24,25 Deaths were ascertained by 
contact with family members or through the Na-
tional Death Index. Fatal heart disease was con-
firmed on the basis of medical records or autopsy 
reports or, if heart disease was listed as the 
cause of death, on the basis of the death certifi-
cates and evidence of previous heart disease in 
the records. Stroke was diagnosed according to 
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standard criteria, consisting of a constellation of 
neurologic deficits of sudden or rapid onset that 
lasted at least 24 hours or until death.23,26 Stroke 
subtypes were also classified as previously de-
scribed23,26 (see the Supplementary Appendix, 
available with the full text of this article at 
NEJM.org).
For each case participant, a control participant 
was selected randomly from those with stored 
toenail samples who were free of cardiovascular 
disease at the time of the case event (risk-set 
sampling). Controls were matched one to one 
with case subjects according to age (within 1 year), 
sex (cohort-specific), race, smoking status (cur-
rent smoker, former smoker [matched on number 
of years since stopping], or never smoked), and 
month when toenail sample was returned to us.
Mercury and Selenium Exposures
Total mercury and selenium concentrations were 
assessed in the stored toenails by means of neu-
tron-activation analysis (University of Missouri 
Research Reactor). Details of the analytic meth-
ods used and information regarding validation of 
these measures are provided in the Supplemen-
tary Appendix.
Covariate Data Collection
Data on demographic characteristics, risk factors, 
and lifestyle habits were collected by means of 
validated, self-administered questionnaires, with 
the use of the closest preceding questionnaire ad-
ministered before the collection of toenail samples 
from each participant. Smoking status was as-
sessed, including the number of years since quit-
ting in the case of former smokers. Hypertension 
and hypercholesterolemia were self-reported, with 
the validity of these reports confirmed on ran-
dom sampling of medical records. A supplemen-
tary questionnaire was used to confirm self-re-
ported cases of diabetes according to established 
criteria,27 and 98% of these cases were validated 
on comparison with medical records. Information 
on weight and height was obtained; self-reported 
weight was validated against technician-measured 
weight (r = 0.96). Physical activity was assessed 
in terms of metabolic equivalents (METs) with 
the use of validated questionaires.28 Usual die-
tary habits were assessed by means of validated 
semiquantitative food-frequency questionnaires 
that inquired about usual consumption of foods, 
beverages, and supplements during the previous 
year.29,30
Statistical Analysis
Associations of mercury concentrations with in-
cident cardiovascular disease were evaluated with 
the use of multivariate-adjusted conditional logis-
tic regression. Given risk-set sampling, this model 
provides a direct estimation of the hazard ratio 
(hereafter referred to as relative risk). Mercury 
concentrations were evaluated in quintiles as in-
dicator variables, with the use of sex-specific cut-
off points among controls. Tests for trend in-
volved assigning participants the median value in 
their quintile of exposure and evaluating this as a 
continuous variable. Tests for interaction involved 
multiplying this variable by the effect modifier of 
interest and using the Wald test to calculate the 
P value associated with the multiplicative interac-
tion term. A potential nonlinear dose–response 
relationship was evaluated by visual inspection of 
relative risks across deciles of exposure. Analyses 
were performed separately in each cohort and 
then combined on the basis of the absence of 
significant effect modification (multiplicative in-
teraction) by sex (P≥0.05). Power calculations are 
provided in the Supplementary Appendix.
Potential confounding was assessed with the 
use of multivariate models adjusted for match-
ing characteristics, other major risk factors for 
cardiovascular disease, fish or n−3 fatty acid con-
sumption, and additional dietary factors associ-
ated with mercury concentrations. Multivariate 
modeling was guided by the principle of parsi-
mony and by the clinical relevance of covariates, 
the observed strength of association between co-
variates and exposure or outcome, and the per-
cent change in the risk estimate when covariates 
were included. Missing data for covariates (which 
accounted for less than 1% of all data) were 
imputed by means of multiple imputation.31
We performed prespecified sensitivity analy-
ses to minimize potential misclassification due 
to exposure changes over time, restricting analy-
ses to events within 10 years of toenail sampling 
and to participants with no substantial change 
in their fish consumption (i.e., a change of no 
more than two quintiles in either direction) from 
baseline to the end of follow-up. Stratified sub-
group analyses were performed with the use of 
unconditional logistic regression adjusted for 
matching factors and other covariates.
All reported P values are two-tailed, with val-
ues less than 0.05 indicating statistical signifi-
cance. All analyses were performed with the use 
of SAS software, version 9.1 (SAS Institute).
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Results
Study Population
We identified 3427 participants with incident cas-
es of cardiovascular disease: 1532 nonfatal myo-
cardial infarctions, 831 fatal cases of coronary 
heart disease, and 1064 strokes. These case par-
ticipants were matched with 3427 controls who 
had not had cardiovascular disease events during 
the same period of follow-up. The median follow-
up interval from the time of toenail sampling to 
the time of a cardiovascular disease event was 
11.3 years (interquartile range, 6.4 to 15.3); follow-
up time was identical for controls, based on the 
risk-set sampling method.
Baseline characteristics are shown in Table 1. 
As expected, cardiovascular risk factors were more 
prevalent among case participants than among 
controls at baseline. Approximately two thirds of 
the study participants were women, reflecting the 
larger size of the NHS cohort as compared with 
the HPFS cohort and the exclusion of dentists in 
the HPFS cohort from the analysis. Mean (±SD) 
ages were 61.1±9.0 years for men and 53.8±6.1 
years for women. Median toenail mercury con-
centrations were 0.30 μg per gram (interdecile 
range, 0.07 to 1.26) in case participants and 
0.31 μg per gram (interdecile range, 0.07 to 1.31) 
in controls among men and 0.21 μg per gram 
(interdecile range, 0.06 to 0.77) in case partici-
pants and 0.23 μg per gram (interdecile range, 
0.07 to 0.76) in controls among women.
Mercury Exposure and Cardiovascular Risk 
Factors
Mercury concentrations correlated modestly with 
fish consumption (r = 0.39, P<0.001) and with es-
timated dietary intake of eicosapentaenoic acid 
and docosahexaenoic acid (EPA–DHA) (r = 0.39, 
P<0.001), as expected, given the predominance of 
seafood as a source of methylmercury exposure 
but also given the considerable variation in methyl-
mercury and n−3 fatty acid content among fish 
species.1,3 Concentrations of mercury did not 
correlate with those of selenium (r = 0.03), a find-
ing that is consistent with the multiple, varied 
dietary sources of selenium.
In bivariate (unadjusted) analyses at baseline 
among the controls, higher mercury concentra-
tions were associated with a more frequent preva-
lence of hypercholesterolemia, slightly lower body-
mass index, modestly higher levels of physical 
activity, greater alcohol use, and lower total en-
ergy intake (Table 1 in the Supplementary Appen-
dix). Mercury concentrations were also positively 
associated with dietary factors related to fish 
consumption and higher dietary intake of EPA–
DHA, including slightly lower intakes of saturated 
fat, monounsaturated fat, trans fat, and dietary 
cholesterol and slightly higher intakes of protein 
and polyunsaturated fat. Mercury concentrations 
were not significantly associated with age, smok-
ing status, family history, or presence or absence 
of hypertension or diabetes.
Mercury Exposure and Cardiovascular Events
After adjustment for matching factors, partici-
pants with higher mercury exposure did not have 
a higher risk of cardiovascular events (Table 2). 
In fact, those with higher mercury concentrations 
had a lower incidence of coronary heart disease 
(P = 0.006 for trend), stroke (P = 0.09 for trend), 
and total cardiovascular disease (P = 0.002 for 
trend). These inverse associations were not sig-
nificant after further adjustment for other car-
diovascular disease risk factors plus estimated 
dietary EPA–DHA (Table 2). Further adjustment 
for consumption of saturated fat, monounsatu-
rated fat, polyunsaturated fat, trans fat, dietary 
cholesterol, and total energy had little effect on 
the results: the adjusted relative risks for com-
parison of the fifth quintile of mercury exposure 
with the first quintile (“extreme-quintile relative 
risks”) were 0.85 (95% confidence interval [CI], 
0.69 to 1.06) for coronary heart disease, 0.83 (95% 
CI, 0.60 to 1.15) for stroke, and 0.87 (95% CI, 
0.73 to 1.03) for total cardiovascular disease. Ad-
justment for fish consumption instead of dietary 
EPA–DHA also did not alter the findings (data not 
shown). The results were also similar for mercury 
concentrations evaluated in deciles (Table 2 in the 
Supplementary Appendix). In separate analyses 
according to sex, the trend toward a lower inci-
dence of cardiovascular disease with higher mer-
cury concentrations was seen for women but not 
for men (Table 3 in the Supplementary Appendix). 
Interaction tests for sex, however, were not sig-
nificant (P = 0.12, P = 0.14, and P = 0.05 for tests of 
interaction with coronary heart disease, stroke, 
and total cardiovascular disease, respectively).
When coronary heart disease subtypes were 
evaluated, mercury exposure was not associated 
with the risk of nonfatal myocardial infarction 
(extreme-quintile relative risk, 0.84 [95% CI, 
0.65 to 1.08]; P = 0.10 for trend) or fatal coronary 
heart disease (extreme-quintile relative risk, 0.85 
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[95% CI, 0.59 to 1.24]; P = 0.41 for trend). Mer-
cury exposure was also not associated with the 
risk of any stroke subtype (see the Supplemen-
tary Appendix).
Sensitivity Analyses
Because selenium above a threshold of risk may 
provide protection against some forms of mercury 
toxicity, we restricted analyses to participants 
with lower selenium concentrations. Mercury ex-
posure was not associated with a higher risk of 
total cardiovascular disease, coronary heart dis-
ease, or stroke among participants with selenium 
levels in the lowest quartile (<0.70 μg per gram) 
or the lowest decile (<0.64 μg per gram) (Table 
3). Mercury exposure was also not associated 
with a higher risk in analyses stratified accord-
ing to fish consumption (Table 4). Results were 
also similar in analyses stratified according to 
the presence or absence of hypertension, high 
Table 1. Baseline Characteristics of Case Participants with Incident Cardiovascular Disease and of Controls.*
Characteristic Men Women
Case Participants
(N = 1211)
Controls
(N = 1211) P Value
Case Participants
(N = 2216)
Controls
(N = 2216) P Value
Age (yr)† 61.1±9.0 61.1±9.0 0.96 53.8±6.1 53.8±6.1 0.86
Smoking status (%)†
Never smoked 40.3 42.4 0.30 35.5 35.5 1.00
Former smoker 44.7 45.9 0.54 25.2 25.7 0.70
Current smoker 11.6 10.5 0.36 39.3 38.8 0.74
Family history of MI (%) 39.0 34.1 0.01 27.4 20.6 <0.001
Hypertension (%) 36.9 21.5 <0.001 13.5 8.1 <0.001
Hypercholesterolemia (%) 13.4 12.1 0.33 6.6 4.2 <0.001
Diabetes mellitus (%) 7.0 3.4 <0.001 3.0 0.5 <0.001
Body-mass index‡ 26.3±3.3 25.5±3.0 0.89 25.9±5.7 24.6±4.7 <0.001
Physical activity (METS/wk) 15.8±21.3 19.4±26.4 <0.001 11.7±16.2 13.5±18.6 0.001
Alcohol (drinks/wk) 0.8±1.2 0.9±1.2 0.08 0.5±0.9 0.6±0.9 0.03
Toenail selenium (μg/g) 0.92±0.61 0.92±0.6 0.99 0.78±0.22 0.78±0.25 0.34
Toenail mercury (μg/g) 0.51±2.13 0.44±0.47 0.24 0.29±0.49 0.33±0.63 0.04
Dietary intake
Fish (servings/wk) 2.1±1.9 2.1±1.8 0.89 1.8±1.6 1.8±1.6 0.65
EPA and DHA (mg/wk) 270±239 264±220 0.49 184±162 184±151 0.89
Total energy intake (kcal/day) 2024±623 2063±640 0.13 1742±536 1727±530 0.38
Fat (% energy)
Total 32.5±6.4 32.6±6.3 0.72 34.8±6.4 34.6±6.4 0.22
Saturated 11.3±2.9 11.3±2.8 0.85 12.7±3.1 12.6±3.0 0.05
Monounsaturated 12.5±2.8 12.5±2.7 0.69 12.9±2.9 12.8±2.9 0.16
Polyunsaturated 5.8±1.6 5.8±1.5 0.42 6.3±1.8 6.4±1.8 0.14
Trans 1.3±0.5 1.3±0.5 0.78 1.9±0.7 1.9±0.6 0.12
Protein (% energy) 18.3±3.4 18.3±3.3 0.97 18.0±3.6 17.9±3.4 0.48
Cholesterol (mg/day) 314±153 320±159 0.32 312±138 308±141 0.40
Whole grains (g/day) 20.5±19.2 20.8±18.0 0.74 15.3±15.9 15.8±13.7 0.28
* Plus–minus values are means ±SD. DHA denotes docosahexaenoic acid, EPA eicosapentaenoic acid, METS metabolic equivalents, and MI 
myocardial infarction.
† Age and smoking status were matching factors.
‡ The body-mass index is the weight in kilograms divided by the square of the height in meters.
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cholesterol, or diabetes or, among women, use or 
nonuse of hormone-replacement therapy (data not 
shown). The results of additional sensitivity analy-
ses are provided in the Supplementary Appendix.
Discussion
In our study, mercury exposure as assessed by an 
objective biomarker measurement was not asso-
ciated with an increased risk of cardiovascular 
disease among men or women in two separate 
U.S. cohorts. An increased risk with greater mer-
cury exposure was also not evident among par-
ticipants with lower selenium concentrations, in 
analyses restricted to the first 10 years of follow-
up and analyses stratified according to the dura-
tion of follow-up, or in analyses restricted to those 
participants without substantial changes in fish 
consumption over time and analyses stratified 
according to the level of fish consumption. These 
findings provide no support for clinically rele-
vant adverse effects of typical levels of dietary 
methylmercury exposure on cardiovascular dis-
ease in U.S. adults.
Higher mercury exposures were actually asso-
ciated with trends toward lower cardiovascular 
disease risk, although these trends were not 
significant in the fully adjusted models. To our 
Table 2. Relative Risk of Cardiovascular Disease, According to Quintile of Toenail Mercury, Among Case Participants and Matched Controls 
in Two Prospective Cohorts of Men and Women.*
Variable
No. of Case 
Participants Sex-Specific Quintile of Toenail Mercury
P Value 
for Trend
1 2 3 4 5
Mean mercury (μg/g) 0.09 0.17 0.25 0.38 0.95
Coronary heart disease 2363
No. of cases 542 506 446 450 419
Multivariate RR (95% CI)
Model 1† 1.00
(reference)
0.97
(0.81–1.15)
0.82
(0.69–1.00)
0.81
(0.68 – 0.97)
0.78
(0.65–0.94)
0.006
Model 2‡ 1.00
(reference)
1.00
(0.83–1.20)
0.89
(0.73–1.08)
0.87
(0.72–1.06)
0.85
(0.69–1.04)
0.10
Stroke 1064
No. of cases 233 226 209 209 187
Multivariate RR (95% CI)
Model 1† 1.00
(reference)
0.91
(0.70–1.19)
0.89
(0.68–1.17)
0.94
(0.72–1.23)
0.77
(0.59–1.02)
0.09
Model 2‡ 1.00
(reference)
0.95
(0.72–1.26)
0.95
(0.71–1.28)
0.98
(0.73–1.31)
0.84
(0.62–1.14)
0.27
Total cardiovascular disease 3427
No. of cases 775 732 655 659 606
Multivariate RR (95% CI)
Model 1† 1.00
(reference)
0.95
(0.82–1.10)
0.84
(0.73–0.98)
0.85
(0.74–0.99)
0.78
(0.67–0.91)
0.002
Model 2‡ 1.00
(reference)
0.98
(0.84–1.15)
0.91
(0.77–1.07)
0.91
(0.77–1.07)
0.85
(0.72–1.01)
0.06
* Values for quintiles represent mean mercury levels. Quintiles were not constructed with the data from men and women combined but were 
sex-specific, and the relative risks (RR) for each were then combined. CI denotes confidence interval.
† In Model 1, the RR is based on conditional logistic regression with risk-set sampling, in which the odds ratio directly estimates the hazard 
ratio or RR, with matching factors of age, sex, race, month of toenail receipt, and smoking status (never smoked, former smoker, or current 
smoker).
‡ In Model 2, the RR was further adjusted for body-mass index (quintiles), physical activity (metabolic equivalents per week, quintiles), alco-
hol intake (drinks per week, quintiles), diabetes (yes or no), hypertension (yes or no), elevated cholesterol level (yes or no), and estimated 
dietary intake of eicosapentaenoic acid and docosahexaenoic acid (mg per week, quintiles).
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knowledge, there is no biologic explanation for 
why mercury would induce cardiovascular bene-
fits. These results plausibly reflect the extent to 
which mercury levels are an indirect, but none-
theless objective, biomarker of fish consumption 
and its correlates and thus probably provide in-
dependent information on how much fish a per-
son consumes, even after adjustment for estimat-
ed consumption. Trends toward lower risk with 
higher mercury exposure appeared to be con-
fined to women, but this sex difference was not 
significant and is probably due to chance. Trends 
toward lower cardiovascular disease risk with 
higher mercury levels have also been seen in 
some prior studies.7,11 Of six prior studies of the 
relationship between mercury exposure and car-
diovascular disease,6-11 only two showed positive 
associations.6,7 The largest study (684 cases) in-
cluded only nonfatal myocardial infarction and 
was retrospective,6 raising concern about possi-
ble selection bias. A smaller, prospective study 
(282 cases) showed a positive association with 
total coronary events but without a clear dose–
response relationship or significant associations 
with coronary or cardiovascular mortality.7 The 
remaining four studies were prospective and did 
not show significant associations; however, they 
included participants with occupational exposure 
to mercury vapor,8 the health effects of which 
differ from those of methylmercury12; they as-
sessed erythrocyte mercury levels, which reflect 
a more recent exposure than do toenail or hair 
concentrations9; or they had small numbers of 
cases (<100).10,11 Several of the prior studies also 
Table 3. Odds Ratios for Cardiovascular Disease (CVD) According to Quintile of Toenail Mercury in Case Participants with Lower Selenium 
Levels, for Men and Women Combined from Two Prospective Cohorts.
Variable
No. of Case 
Participants Sex-Specific Quintile of Toenail Mercury*
P Value 
for Trend
1 2 3 4 5
odds ratio (95% confidence interval)
Subjects in lowest quartile 
of selenium levels†
Coronary heart disease 631 1.00
(reference)
0.94
(0.65–1.37)
0.72
(0.50–1.05)
0.71
(0.48–1.05)
0.84
(0.55–1.27)
0.46
Stroke 254 1.00
(reference)
0.70
(0.39–1.27)
0.88
(0.49–1.57)
0.59
(0.31–1.12)
0.40
(0.20–0.79)
0.006
Total CVD 885 1.00
(reference)
0.87
(0.64–1.18)
0.78
(0.58–1.07)
0.70
(0.50–0.96)
0.68
(0.48–0.96)
0.03
Subjects in lowest decile  
of selenium levels‡
Coronary heart disease 242 1.00
(reference)
0.99
(0.54–1.81)
0.74
(0.40–1.36)
0.77
(0.40–1.48)
0.79
(0.40–1.57)
0.49
Stroke 111 1.00
(reference)
1.02
(0.39–2.69)
1.02
(0.40–2.54)
0.81
(0.28–2.32)
0.62
(0.38–1.17)
0.30
Total CVD 353 1.00
(reference)
0.94
(0.57–1.55)
0.80
(0.49–1.30)
0.78
(0.46–1.34)
0.67
(0.38–1.17)
0.14
* Quintile cutoff points are based on the overall control population (see Table 3 in the Supplementary Appendix). An unconditional logistic- 
regression model was used, as appropriate, for stratified subgroup analyses. Values were adjusted for age, sex, race, month of toenail re-
ceipt, smoking status (never smoked, former smoker, or current smoker), body-mass index (quintiles), physical activity (metabolic equiva-
lents per week, quintiles), alcohol use (drinks per week, quintiles), diabetes (yes or no), hypertension (yes or no), elevated cholesterol level 
(yes or no), and estimated dietary intake of eicosapentaenoic acid and docosahexaenoic acid (mg per week, quintiles).
† These subjects had selenium values below 0.70 μg per gram.
‡ These subjects had selenium values below 0.64 μg per gram.
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did not evaluate stroke6-8,11 or include women.6-8 
The investigation we describe here was designed 
to overcome these limitations.
With respect to generalizability, it is impor-
tant to consider how mercury exposures in the 
present study compare with those in prior studies 
and with average population exposures. In our 
highest exposure quintile, the median toenail 
mercury concentration was 0.68 μg per gram, 
and in our highest decile, 1.00 μg per gram, 
corresponding to hair concentrations of about 
1.84 and 2.70 μg per gram, respectively, calcu-
lated from a reported toenail-to-hair ratio of 
mercury of about 0.37.32-35 These exposure levels 
are similar to those seen in two smaller studies, 
in which mercury levels were positively associ-
ated with coronary heart disease risk,6,7 and are 
also similar to higher U.S. exposures (in the 95th 
percentile).36
Differences in population selenium levels have 
been hypothesized to explain discrepant find-
ings of prior studies with respect to mercury and 
cardiovascular risk — in particular, a study from 
Finland.7 Before soil supplementation was begun 
in the 1980s, selenium levels in Finland were 
among the lowest in Europe (mean serum level, 
Table 4. Odds Ratios for Total Cardiovascular Disease, According to Quintile of Toenail Mercury and Stratum of Fish Consumption, for Men 
and Women Combined from Two Prospective Cohorts.
Fish Consumption*
No. of Case 
Participants Quintile of Toenail Mercury†
P Value 
for Trend
1 2 3 4 5
odds ratio (95% confidence interval)
Total
<1 serving/wk 1500 1.00
(reference)
0.99
(0.81–1.21)
0.91
(0.73–1.13)
0.80
(0.63–1.01)
0.90
(0.69–1.18)
0.20
1 to <2 servings/wk 992 1.00
(reference)
0.85
(0.63–1.14)
0.98
(0.73–1.32)
0.84
(0.62–1.13)
0.74
(0.54–1.02)
0.07
≥2 servings/wk 935 1.00
(reference)
1.11
(0.74–1.66)
0.79
(0.54–1.17)
1.17
(0.80–1.70)
0.96
(0.66–1.39)
0.86
Tuna or other dark-meat fish
<1 serving/wk 2475 1.00
(reference)
1.00
(0.85–1.18)
0.93
(0.78–1.10)
0.88
(0.73–1.05)
0.93
(0.76–1.13)
0.32
1 to <2 servings/wk 483 1.00
(reference)
0.72
(0.42–1.22)
0.69
(0.42–1.15)
0.89
(0.54–1.47)
0.58
(0.35–0.95)
0.08
≥2 servings/wk 469 1.00
(reference)
0.98
(0.54–1.79)
0.81
(0.46–1.44)
0.97
(0.56–1.69)
0.81
(0.47–1.39)
0.38
Other fish
<0.5 serving/wk 2121 1.00
(reference)
0.99
(0.83–1.19)
0.92
(0.76–1.11)
0.87
(0.71–1.06)
0.86
(0.69–1.06)
0.10
0.5 to <1 servings/wk 932 1.00
(reference)
0.91
(0.66–1.25)
0.90
(0.65–1.24)
0.88
(0.64–1.22)
0.74
(0.54–1.03)
0.06
≥1 servings/wk 374 1.00
(reference)
1.05
(0.54–2.64)
0.88
(0.47–1.63)
1.29
(0.71–2.35)
1.38
(0.76–2.48)
0.08
* Total fish consumption was the sum of the consumption of tuna or other dark-meat fish and the consumption of other fish. Strata were set 
at logical cutoff points that provided reasonable numbers of cases per stratum.
† Quintile cutoff points are based on the overall control population (see Table 3 in the Supplementary Appendix). Thus, in every stratum of 
fish consumption, higher quintiles reflect subjects with similarly high mercury exposure. In the case of low fish consumption (e.g., <1 serving 
per week), higher quintiles would be consistent with more exclusive consumption of relatively contaminated fish (i.e., similar methylmercury 
exposure from fewer fish meals, indicating a greater proportion of more contaminated fish in the diet). Values are based on unconditional 
logistic regression, as appropriate, for stratified subgroup analyses and have been adjusted for age, sex, race, month of toenail receipt, 
smoking status (never, former, or current), body-mass index (quintiles), physical activity (metabolic equivalents per week, quintiles), alcohol 
(drinks per week, quintiles), diabetes (yes or no), hypertension (yes or no), elevated cholesterol (yes or no), and estimated dietary intake of 
eicosapentaenoic acid and docosahexaenoic acid (mg per week, quintiles). See Tables 5 and 6 in the Supplementary Appendix for stratified 
results for coronary heart disease and stroke, which were evaluated separately.
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<70 μg per liter).37 In the Finnish mercury study, 
average serum selenium levels at baseline (from 
1984 through 1989, after soil supplementation 
began) were higher (117 μg per liter)7 but still 
below average U.S. levels (138 μg per liter).38 In 
our study, we found no evidence of an increased 
risk with higher mercury levels, even among par-
ticipants with selenium levels in the lowest de-
cile (<0.64 μg per gram in toenails, approxi-
mately equivalent to <91 μg per liter in serum39). 
We also found no evidence that mercury was 
harmful among participants in different strata of 
fish consumption, including those with low fish 
consumption, in whom higher mercury levels 
would suggest more exclusive consumption of 
mercury-contaminated fish.
Our analysis cannot exclude the possibility of 
mercury-related cardiovascular toxicity at higher 
exposures than those observed in our cohorts or 
in the setting of frank selenium deficiency, which 
would be rare in U.S. cohorts. Ecologic or small 
cross-sectional studies in more highly exposed 
populations in the Amazon,40 the Faroe Islands,32 
and Asia41,42 suggest that methylmercury expo-
sure may be associated with higher blood pres-
sure or lower parasympathetic activity; ecologic 
evidence of an increased risk of clinical cardio-
vascular events is lacking.43
Our analysis has potential limitations. Al-
though toenail concentrations of mercury pro-
vide an excellent biomarker of integrated, usual 
methylmercury exposure during the previous year, 
changes in dietary exposure over time could 
attenuate true relationships toward null. Toenail 
mercury concentration serves as a marker of fish 
consumption, and our findings may be partly 
confounded by the beneficial effects of fish in-
take, despite adjustment for responses to the 
dietary questionnaire; this might account for 
trends toward lower risk. Although the findings 
were similar in the two independent cohorts and 
there is little reason to believe that biologic effects 
of methylmercury in these populations would be 
different from those in the general population of 
women and men, these cohorts comprised large-
ly white, educated U.S. adults, potentially limit-
ing generalizability.
The absence of any association between mer-
cury exposure and increased cardiovascular dis-
ease risk in adults should not alter ongoing public 
health and policy efforts to reduce mercury con-
tamination in fish and the environment, which 
could still have the potential to offset, at least in 
part, the net cardiovascular benefits of fish con-
sumption. Our findings should also not alter 
advisories directed toward women who are or 
may become pregnant or who are nursing, since 
methyl mercury exposure from consumption of 
specific fish species could cause neurodevelop-
mental harm, or at least partly offset the neuro-
developmental benefits of fish consumption, in 
their children.
In summary, this prospective study of two 
large cohorts of men and women in the United 
States showed no evidence of a relationship be-
tween mercury exposure and increased cardio-
vascular disease risk.
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